You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

NK1 Receptor antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prurigo Nodularis Trial in Germany (serlopitant, Placebo)

Completed
Has Results
  • Prurigo Nodularis
  • Berlin-Mitte, Germany
  • +14 more
May 18, 2021

Gynecologic Cancer Trial in Ann Arbor (Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA))

Recruiting
  • Gynecologic Cancer
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 6, 2022

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

Not yet recruiting
  • Myeloma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus Trial in Lahore (NK-1R antagonist)

Unknown status
  • Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
  • NK-1R antagonist
  • Lahore, Punjab, Pakistan
    Bahria International Hospital
Jul 10, 2020

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting
  • Depressive Disorder, Major
  • Anxiety Disorder
  • Nociceptin Receptor Antagonist
  • Aversive stimuli
  • (no location specified)
Nov 3, 2022

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Netosis During COVID-19, Under Treatment With

Active, not recruiting
  • Covid19
    • Paris, France
    • +1 more
    Mar 30, 2022

    Spinal Cord Injuries Trial in Toledo (Rimonabant)

    Not yet recruiting
    • Spinal Cord Injuries
    • Toledo, Spain
      Hospital Nacional de Paraplejicos
    Nov 14, 2022

    Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)

    Recruiting
    • Burns
    • Shanghai, Shanghai, China
      Department of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
    Nov 6, 2023

    Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

    Recruiting
    • Adamantinomatous Craniopharyngioma
    • Recurrent Adamantinomatous Craniopharyngioma
    • Aurora, Colorado
    • +17 more
    Jan 8, 2023

    Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer Trial (MB1707)

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • (no location specified)
    Jul 18, 2022

    Pancreatitis, Acute Trial in Denmark, Sweden (Placebo treatment, Naldemedine 0.2 MG Oral Tablet)

    Recruiting
    • Pancreatitis, Acute
    • Placebo treatment
    • Naldemedine 0.2 MG Oral Tablet
    • Aalborg, Jutland, Denmark
    • +4 more
    Mar 7, 2022

    Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

    Completed
    • Intracerebral Haemorrhage
    • IL-1Ra Kineret®
    • IL-1Ra Placebo
    • Manchester, North West, United Kingdom
      Salford Royal NHS Foundation Trust
    Oct 4, 2021

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 18, 2023

    Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

    Enrolling by invitation
    • Chronic Kidney Diseases
    • Aurora, Colorado
    • +5 more
    Oct 18, 2022

    Rectal Cancer Trial in New York (Etrumadenant (AB928), Radiation therapy, FOLFOX regimen)

    Recruiting
    • Rectal Cancer
    • Etrumadenant (AB928)
    • +3 more
    • New York, New York
    • +2 more
    Apr 10, 2022

    Diabetes Type 2 in Obese, Inflammation, Metabolic Disease Trial in Basel (Anakinra Prefilled Syringe)

    Recruiting
    • Diabetes Mellitus Type 2 in Obese
    • +3 more
    • Anakinra Prefilled Syringe
    • Basel, Basel BS, Switzerland
      University Hospital Basel
    Sep 7, 2021